Skip to main content
TipRanks
Go Ultimate75% OFF

Neupath Health Inc. (NPTH) Stock Forecast & Price Target

5 Followers
See the Price Targets and Ratings of:

NPTH Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Neupath Health Inc. in the past 3 months

NPTH Stock 12 Month Forecast

C$0.68▲(25.93% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Neupath Health Inc. in the last 3 months. The average price target is CAD 0.68 with a high forecast of CAD 0.68 and a low forecast of CAD 0.68. The average price target represents a 25.93% change from the last price of CAD 0.54.
Highest Price TargetC$0.68Average Price TargetC$0.68Lowest Price TargetC$0.68

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for TSE:NPTH
Price TargetArticle
Stifel NicolausC$0.68buy25.93%UpsideReiterated09/16/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Neupath Health Inc.

3 Months
Justin Keywood
Justin KeywoodStifel Nicolaus
Success Rate5/7 ratings generated profit
71%
Average Return
+13.61%

Copying Justin Keywood's trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +13.61% per trade.

1 Year
Justin Keywood
Justin KeywoodStifel Nicolaus
Success Rate6/7 ratings generated profit
86%
Average Return
+40.26%

Copying Justin Keywood's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +40.26% per trade.

2 Years
Justin Keywood
Justin KeywoodStifel Nicolaus
Success Rate6/7 ratings generated profit
86%
Average Return
+41.27%

Copying Justin Keywood's trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +41.27% per trade.

NPTH Analyst Recommendation Trends

00.511.52Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for NPTH
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy00111
Hold00000
Sell00000
Strong Sell00000
total00111

In the current month, NPTH has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NPTH average Analyst price target in the past 3 months is 0.68.

NPTH Financial Forecast

C$-2C$-1.25C$-0.5C$0.25C$1Q1 2026Q3 2026Q4 2026
ConsensusC$0.00

NPTH Earnings Forecast

Next quarter’s earnings estimate for NPTH is CAD 0.00 with a range of ― to ―. The previous quarter’s EPS was CAD 0.00. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

C$21.5MC$22.3MC$23.1MC$23.8MC$24.6MQ1 2026Q3 2026Q4 2026
HighC$24.6M
ConsensusC$24.6M
LowC$24.6M

NPTH Sales Forecast

Next quarter’s sales forecast for NPTH is CAD 24.60M with a range of CAD 24.60M to CAD 24.60M. The previous quarter’s sales results were CAD 22.34M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

NPTH Stock Forecast FAQ

What is TSE:NPTH’s average 12-month price target, according to analysts?
Based on analyst ratings, Neupath Health Inc.’s 12-month average price target is C$0.68.
What is TSE:NPTH’s upside potential, based on the analysts’ average price target?
Neupath Health Inc. has 25.93% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TSE:NPTH a Buy, Sell or Hold?
Neupath Health Inc. has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Neupath Health Inc.’s price target?
The average price target for Neupath Health Inc. is C$0.68. This is based on 1 12-month price targets, issued in the past 3 months. The highest analyst price target is C$0.68, the lowest forecast is C$0.68. The average price target represents a 25.93% increase from the current price of C$0.54.
What do analysts say about Neupath Health Inc.?
Neupath Health Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of TSE:NPTH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.